These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

962 related items for PubMed ID: 16860170

  • 1. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF, Foley KA, Barlas S, Solomon G, Hu XH.
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [Abstract] [Full Text] [Related]

  • 2. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Cady R, Martin V, Adelman J, Diamond M, Sajjan S, Hu XH.
    Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
    [Abstract] [Full Text] [Related]

  • 3. Migraine treatment with rizatriptan and almotriptan: a crossover study.
    Ng-Mak DS, Hu XH, Bigal M.
    Headache; 2009 May; 49(5):655-62. PubMed ID: 19456878
    [Abstract] [Full Text] [Related]

  • 4. Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
    Ng-Mak DS, Hu XH, Chen Y, Ma L, Solomon G.
    Int J Clin Pract; 2007 Jul; 61(7):1091-111. PubMed ID: 17537184
    [Abstract] [Full Text] [Related]

  • 5. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J, García-Moncó C, Roig C, Yusta Izquierdo A, López-Gil A, eMAX Study Group.
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [Abstract] [Full Text] [Related]

  • 6. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R, Rizatriptan Protocol 059 and 061 Study Groups.
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R, Crawford G, Ahrens S, Hairwassers D, Getson A, Visser WH, Lines C, Rizatriptan-RPD Study Group.
    MedGenMed; 2001 Jun 01; 3(3):1. PubMed ID: 11549974
    [Abstract] [Full Text] [Related]

  • 8. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr 01; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 9. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.
    Baos V, Serrano A, Torrecilla M, Bertral C, Caloto MT, Nocea G, Gerth WC, I-MAX Study Group.
    Int J Clin Pract; 2003 Nov 01; 57(9):761-8. PubMed ID: 14686564
    [Abstract] [Full Text] [Related]

  • 10. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Láinez MJ, Evers S, Kinge E, Allais G, Allen C, Rao NA, Massaad R, Lis K.
    Cephalalgia; 2006 Mar 01; 26(3):246-56. PubMed ID: 16472330
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Feb 01; 48(2):226-35. PubMed ID: 18005144
    [Abstract] [Full Text] [Related]

  • 12. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb 01; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 13. Early treatment of migraine with rizatriptan: a placebo-controlled study.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2004 Feb 01; 44(7):669-73. PubMed ID: 15209688
    [Abstract] [Full Text] [Related]

  • 14. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J, Tiseo PT, Albert KS, Li C, Sikes CR.
    Headache; 2006 Feb 01; 46(7):1142-50. PubMed ID: 16866718
    [Abstract] [Full Text] [Related]

  • 15. Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study.
    Láinez MJ, López A, Pascual AM.
    Headache; 2005 Feb 01; 45(7):883-90. PubMed ID: 15985105
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL, Taylor FR, Friedman D, Newman L, Ge Y, Zhang Y, Hustad CM, Lasorda J, Fan X, Hewitt D, Ho T, Connor KM.
    Cephalalgia; 2011 May 01; 31(7):786-96. PubMed ID: 21078681
    [Abstract] [Full Text] [Related]

  • 17. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
    Mateos V, Roig C, López Rodríguez I, López-Gil A.
    Neurologia; 2002 Dec 01; 17(10):621-7. PubMed ID: 12487957
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
    Cady R, Martin V, Mauskop A, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2006 Jun 01; 46(6):914-24. PubMed ID: 16732837
    [Abstract] [Full Text] [Related]

  • 19. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr 01; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

  • 20. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr 01; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.